Announcements Trials
Browse Landscape

Phase

Phase 2 8Phase 3 5Phase 1 4Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

HR Positive HER2 Negative Advanced Breast Cancer 1Carcinoma, Intraductal, Noninfiltrating 1Breast Neoplasms 1Breast Carcinoma In Situ 1Advanced HR - Positive, HER2 - Negative Breast Cancer 1Advanced Breast Cancer 1

Interventions

disitamab vedotin 1N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1Fulvestrant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Advanced Breast Cancer × Fulvestrant × Clear all
NCT05047848 2021-09-17

Clinical Study of Chidamide Combined With Fulvestrant in the Treatment of Hormone Receptor-positive Advanced Breast Cancer

Liaoning Cancer Hospital & Institute

Phase NA Unknown
82 enrolled
Breast

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡